UPDATE 1-Sanofi, Regeneron submit new cholesterol drug to EMA for review

PARIS, Jan 12 (Reuters) - The European Medicines Agency has agreed to review an application by Sanofi and Regeneron for their cholesterol-lowering drug alirocumab, the pharmaceutical groups said in a statement on Monday.